Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | MGAM | O43451 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | SI | P14410 | 1/20 | 0.35 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.30 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.30 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butanone SCHEMBL3678047 | 0.98 | ALDH1A1 (0.48) | ALDH1A1TDP1TSHRMGAMGAA | |
| Acetone SCHEMBL7668393 | 0.90 | TSHR (0.48) | ALDH1A1TDP1TSHRMGAMGAA | |
| Acetic Acid SCHEMBL29076 | 0.87 | TSHR (0.46) | ALDH1A1TDP1TSHRMGAMGAA | |
| Acetic Acid Methyl Ester SCHEMBL3409715 | 0.85 | ALDH1A1 (0.50) | ALDH1A1TDP1TSHRMGAMGAA | |
| SCHEMBL16668528 | 0.84 | — | — | |
| SCHEMBL20648 | 0.84 | — | — | |
| SCHEMBL13611580 | 0.84 | — | — | |
| SCHEMBL5487434 | 0.81 | — | — | |
| Methyl Alcohol SCHEMBL14861497 | 0.81 | — | — | |
| Magnesium SCHEMBL31182158 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9993997-B2 | Laminate and process for producing same | MITSUBISHI CABLE INDUSTRIES, LTD. (JP) | 2018-06-12 | — | — | US | disclosed |
| EP-2962843-B1 | LAMINATE AND PROCESS FOR PRODUCING SAME | MITSUBISHI CABLE IND LTD (JP) | 2017-05-31 | — | — | EP | disclosed |
| US-20160001523-A1 | LAMINATE AND PROCESS FOR PRODUCING SAME | MITSUBISHI CABLE INDUSTRIES, LTD. (JP) | 2016-01-07 | — | — | US | disclosed |
| EP-2962843-A1 | LAMINATE AND PROCESS FOR PRODUCING SAME | Mitsubishi Cable Industries, Ltd. (JP) | 2016-01-06 | — | — | EP | disclosed |
| US-20090280331-A1 | PHOSPHORUS-CONTAINING BENZOXAZINE COMPOUND, PROCESS FOR PRODUCTION THEREOF, CURABLE RESIN COMPOSITION, CURED ARTICLE, AND LAMINATE PLATE | SHOWA HIGHPOLYMER CO., LTD. (JP) | 2009-11-12 | — | — | US | disclosed |
| US-20090274916-A1 | PHOSPHORUS-CONTAINING BENZOXAZINE COMPOUND, PROCESS FOR PRODUCTION THEREOF, CURABLE RESIN COMPOSITION, CURED ARTICLE, AND LAMINATE PLATE | SHOWA HIGHPOLYMER CO., LTD (JP) | 2009-11-05 | — | — | US | disclosed |
| EP-2050756-A1 | PHOSPHORUS-CONTAINING BENZOXAZINE COMPOUND, PROCESS FOR PRODUCTION THEREOF, CURABLE RESIN COMPOSITION, CURED ARTICLE, AND LAMINATE PLATE | SHOWA HIGHPOLYMER CO., LTD. (JP) | 2009-04-22 | — | — | EP | disclosed |
| EP-2048147-A1 | PHOSPHORUS-CONTAINING BENZOXAZINE COMPOUND, PROCESS FOR PRODUCTION THEREOF, CURABLE RESIN COMPOSITION, CURED ARTICLE, AND LAMINATE PLATE | SHOWA HIGHPOLYMER CO., LTD. (JP) | 2009-04-15 | — | — | EP | disclosed |
| US-6376053-B1 | BLEND OF EPOXY RESIN AND CURING AGENTS | AJINOMOTO CO., INC. (JP) | 2002-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090274916-A1 | PHOSPHORUS-CONTAINING BENZOXAZINE COMPOUND, PROCESS FOR PRODUCTION THEREOF, CURABLE RESIN COMPOSITION, CURED ARTICLE, AND LAMINATE PLATE | P2RX5, P2RX4, KDM5A | ALDH1A1 2049/4885TDP1 906/4885TSHR 4464/4885 |
| US-20090280331-A1 | PHOSPHORUS-CONTAINING BENZOXAZINE COMPOUND, PROCESS FOR PRODUCTION THEREOF, CURABLE RESIN COMPOSITION, CURED ARTICLE, AND LAMINATE PLATE | P2RX5, KDM5A, P2RX4 | ALDH1A1 1946/4885TDP1 1097/4885TSHR 4511/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.